Glutamate receptor delta 1 (GRID1) genetic variation and brain structure in schizophrenia

Journal of Psychiatric Research

Volumn 46, Issue 12, 2012, Pages 1531-1539

  Nenadic, Igor ^a   Maitra, Raka ^a   Scherpiet, Sigrid ^a   Gaser, Christian ^a   Schultz, C Christoph ^a   Schachtzabel, Claudia ^a   Smesny, Stefan ^a   Reichenbach, Jürgen R ^a   Treutlein, Jens ^b   Mühleisen, Thomas W ^c   Deufel, Thomas ^a   Cichon, Sven ^c,d   Rietschel, Marcella ^b   Nöthen, Markus M ^c   Sauer, Heinrich ^a   Schlösser, Ralf G M ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

GRID1; Magnetic resonance imaging (MRI); Prefrontal cortex; Rs3814614; Thalamus; Voxel based morphometry (VBM)

Indexed keywords

ADULT; ALLELE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUTAMATE RECEPTOR DELTA 1 GENE; GRAY MATTER; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ORBITAL CORTEX; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; THALAMUS ANTERIOR NUCLEUS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84868133343     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.08.026     Document Type: Article

References (40)

1. Agarwal N., Rambaldelli G., Perlini C., Dusi N., Kitis O., Bellani M., et al. Microstructural thalamic changes in schizophrenia: a combined anatomic and diffusion weighted magnetic resonance imaging study. Journal of Psychiatry & Neuroscience 2008, 33:440-448.
2. Aggleton J.P., O'Mara S.M., Vann S.D., Wright N.F., Tsanov M., Erichsen J.T. Hippocampal-anterior thalamic pathways for memory: uncovering a network of direct and indirect actions. European Journal of Neuroscience 2010.
3. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature Genetics 2008, 40:827-834.
4. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. Neuroimage 2000, 11:805-821.
5. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
6. Balciuniene J., Feng N., Iyadurai K., Hirsch B., Charnas L., Bill B.R., et al. Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. American Journal of Human Genetics 2007, 80:938-947.
7. Byne W., Hazlett E.A., Buchsbaum M.S., Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathologica 2009, 117:347-368.
8. Chen X., Lee G., Maher B.S., Fanous A.H., Chen J., Zhao Z., et al. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular Psychiatry 2011, 16:1117-1129.
9. Corradi-Dell'Acqua C., Tomelleri L., Bellani M., Rambaldelli G., Cerini R., Pozzi-Mucelli R., et al. Thalamic-insular dysconnectivity in schizophrenia: evidence from structural equation modeling. Human Brain Mapping 2012, 33:740-752.
10. Cuadra M.B., Cammoun L., Butz T., Cuisenaire O., Thiran J.P. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging 2005, 24:1548-1565.
11. Danos P., Baumann B., Bernstein H.G., Franz M., Stauch R., Northoff G., et al. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Research 1998, 82:1-10.
12. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. American Journal of Human Genetics 2005, 77:918-936.
13. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006, 31:2022-2032.
14. Guo S.Z., Huang K., Shi Y.Y., Tang W., Zhou J., Feng G.Y., et al. A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophrenia Research 2007, 93:385-390.
15. van Haren N.E., Bakker S.C., Kahn R.S. Genes and structural brain imaging in schizophrenia. Current Opinion in Psychiatry 2008, 21:161-167.
16. Harrison P.J., Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003, 361:417-419.
17. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., Cahn W., Collins D.L., Evans A.C., et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 2004, 21:27-35.
18. Inta D., Monyer H., Sprengel R., Meyer-Lindenberg A., Gass P. Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review. Neuroscience & Biobehavioral Reviews 2010, 34:285-294.
19. Kim D.J., Kim J.J., Park J.Y., Lee S.Y., Kim J., Kim I.Y., et al. Quantification of thalamocortical tracts in schizophrenia on probabilistic maps. Neuroreport 2008, 19:399-403.
20. Kuroyanagi T., Yokoyama M., Hirano T. Postsynaptic glutamate receptor delta family contributes to presynaptic terminal differentiation and establishment of synaptic transmission. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4912-4916.
21. Labrie V., Roder J.C. The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neuroscience & Biobehavioral Reviews 2010, 34:351-372.
22. McFarland N.R., Haber S.N. Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. Journal of Neuroscience 2002, 22:8117-8132.
23. Meyer-Lindenberg A., Nicodemus K.K., Egan M.F., Callicott J.H., Mattay V., Weinberger D.R. False positives in imaging genetics. Neuroimage 2008, 40:655-661.
24. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience 2006, 7:818-827.
25. Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O. Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Research 1999, 6:337-345.
26. Naur P., Hansen K.B., Kristensen A.S., Dravid S.M., Pickering D.S., Olsen L., et al. Ionotropic glutamate-like receptor delta2 binds d-serine and glycine. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14116-14121.
27. Owen M.J., Craddock N., O'Donovan M.C. Schizophrenia: genes at last?. Trends in Genetics 2005, 21:518-525.
28. Patil S.T., Zhang L., Martenyi F., Lowe S.L., Jackson K.A., Andreev B.V., et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nature Medicine 2007, 13:1102-1107.
29. Pinault D. Dysfunctional thalamus-related networks in schizophrenia. Schizophrenia Bulletin 2011, 37:238-243.
30. Schmid S.M., Hollmann M. To gate or not to gate: are the delta subunits in the glutamate receptor family functional ion channels?. Molecular Neurobiology 2008, 37:126-141.
31. Smith M.J., Wang L., Cronenwett W., Mamah D., Barch D.M., Csernansky J.G. Thalamic morphology in schizophrenia and schizoaffective disorder. Journal of Psychiatric Research 2011, 45:378-385.
32. Tan H.Y., Callicott J.H., Weinberger D.R. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cerebral Cortex 2007, 17(Suppl. 1):i171-i181.
33. Thompson M., Weickert C.S., Wyatt E., Webster M.J. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. Journal of Psychiatric Research 2009, 43:970-977.
34. Treutlein J., Muhleisen T.W., Frank J., Mattheisen M., Herms S., Ludwig K.U., et al. Dissection of phenotype reveals possible association between schizophrenia and glutamate receptor delta 1 (GRID1) gene promoter. Schizophrenia Research 2009, 111:123-130.
35. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
36. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64:663-667.
37. Xiao D., Zikopoulos B., Barbas H. Laminar and modular organization of prefrontal projections to multiple thalamic nuclei. Neuroscience 2009, 161:1067-1081.
38. Yadav R., Gupta S.C., Hillman B.G., Bhatt J.M., Stairs D.J., Dravid S.M. Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PLoS One 2012, 7:e32969.
39. Yamazaki M., Araki K., Shibata A., Mishina M. Molecular cloning of a cDNA encoding a novel member of the mouse glutamate receptor channel family. Biochemical and Biophysical Research Communications 1992, 183:886-892.
40. Zhu Y., Kalbfleisch T., Brennan M.D., Li Y. A microRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophrenia Research 2009, 109:86-89.